Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate - Abstract

BACKGROUND: In general population studies, obesity has been associated with risk of high-grade prostate cancer, but little is known about obesity and future prostate cancer risk among men with an initial benign biopsy of the prostate; a high-risk population.

METHODS: Within a cohort of 6,692 men followed up after a biopsy or transurethral resection of the prostate (TURP) with benign findings, a nested case-control study was conducted of 494 prostate cancer cases and controls matched on age, race, follow-up duration, biopsy versus TURP and date of procedure. Body mass index at the time of the initial procedure was abstracted from medical records, and initial biopsy specimens were reviewed for the presence of prostatic intraepithelial neoplasia (PIN).

RESULTS: Obesity was associated with the presence of PIN in the initial benign specimen [OR = 2.15; 95% confidence interval (CI) 1.13-4.11]. After adjustment for the matching variables, family history of prostate cancer, prostate-specific antigen (PSA) levels at the initial procedure, the number of PSA tests and digital rectal examinations during follow-up, obesity (OR = 1.57; 95% CI, 1.07-2.30) at the time of the initial procedure was associated with prostate cancer incidence during follow-up. Risk associated with obesity was confined to cases with follow-up less than 1,538 days, the median duration of follow-up among cases (OR = 1.95; 95% CI, 1.09-3.48).

CONCLUSIONS: Obesity is associated with the presence of PIN in benign specimens and with future prostate cancer risk after an initial benign finding.

IMPACT: Obesity may be a factor to consider when planning clinical follow-up after a benign biopsy.

Written by:
Rundle A, Jankowski M, Kryvenko ON, Tang D, Rybicki BA.   Are you the author?
Columbia University, 722 West 168th Street, Rm 714, New York, NY 10032.

Reference: Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):898-904.
doi: 10.1158/1055-9965.EPI-12-0965

PubMed Abstract
PMID: 23613026

UroToday.com Prostate Cancer Section








Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.